David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Cintas
CTAS
$82.3B
| $3.45M | ﹤0.01% |
30,564
+12,028
| +65% | +$1.3M |
|
2302
PUT
Consolidated Edison
ED
$40B
| $3.45M | ﹤0.01% |
36,200
-1,500
| -4% | -$136K |
|
2303
PUT
Ferrari
RACE
$72.6B
| $3.45M | ﹤0.01% |
16,100
-10,000
| -38% | -$2.06M |
|
2304
ProFrac Holding
ACDC
$841M
| $3.45M | ﹤0.01% |
+136,832
| New | +$3.02M |
|
2305
OneMain Financial
OMF
$7.26B
| $3.45M | ﹤0.01% |
103,492
+9,913
| +11% | +$351K |
|
|
SWI
2306
DELISTED
SolarWinds Corporation Common Stock
SWI
| $3.45M | ﹤0.01% |
368,176
-146,863
| -29% | -$1.28M |
|
|
ZLS
2307
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
| $3.45M | ﹤0.01% |
344,591
| – | – |
|
2308
Central Pacific Financial
CPF
$978M
| $3.45M | ﹤0.01% |
169,880
+8,557
| +5% | +$176K |
|
2309
Nabors Industries
NBR
$1.29B
| $3.44M | ﹤0.01% |
22,214
+19,583
| +744% | +$2.92M |
|
|
VRNA
2310
DELISTED
Verona Pharma
VRNA
| $3.44M | ﹤0.01% |
+131,468
| New | +$1.75M |
|
2311
The Greenbrier Companies
GBX
$1.43B
| $3.43M | ﹤0.01% |
+102,427
| New | +$3.41M |
|
2312
Xcel Energy
XEL
$48.5B
| $3.43M | ﹤0.01% |
48,901
-189,624
| -79% | -$12.6M |
|
2313
Ligand Pharmaceuticals
LGND
$5.74B
| $3.43M | ﹤0.01% |
+51,301
| New | +$3.34M |
|
2314
PUT
Waters Corp
WAT
$40.7B
| $3.43M | ﹤0.01% |
+10,000
| New | +$3.16M |
|
|
CLVT.PRA
2315
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $3.42M | ﹤0.01% |
90,000
| – | – |
|
2316
CALL
Keysight
KEYS
$54.8B
| $3.42M | ﹤0.01% |
20,000
| – | – |
|
2317
Bilibili
BILI
$6.76B
| $3.42M | ﹤0.01% |
+144,292
| New | +$2.3M |
|
|
CUK
2318
DELISTED
Carnival PLC
CUK
| $3.42M | ﹤0.01% |
+475,276
| New | +$3.66M |
|
2319
CALL
Interactive Brokers
IBKR
$44B
| $3.41M | ﹤0.01% |
188,400
| – | – |
|
2320
PUT
STMicroelectronics
STM
$44.3B
| $3.41M | ﹤0.01% |
+95,800
| New | +$3.38M |
|
|
STR
2321
DELISTED
Sitio Royalties
STR
| $3.41M | ﹤0.01% |
118,080
+102,108
| +639% | +$2.96M |
|
|
PRA
2322
DELISTED
ProAssurance
PRA
| $3.41M | ﹤0.01% |
194,911
+94,256
| +94% | +$1.86M |
|
2323
Blackrock
BLK
$182B
| $3.4M | ﹤0.01% |
4,805
-13,794
| -74% | -$9.21M |
|
|
TGVC
2324
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $3.4M | ﹤0.01% |
335,495
| – | – |
|
2325
Allstate
ALL
$66.2B
| $3.4M | ﹤0.01% |
25,065
+14,752
| +143% | +$1.93M |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.